Abstract

IntroductionCancer-related fatigue (CRF) is the most commonly reported treatment-related side effect of prostate cancer (PCa). Recognition of financial hardship among cancer survivors is growing. We investigated, for the first time, associations between levels of financial stress and CRF among PCa survivors.MethodsWe used data from PCa survivors who had been identified through two population-based cancer registries covering the Republic of Ireland and Northern Ireland and had completed a postal questionnaire. CRF was measured by the fatigue subscale of the EORTC QLQ-C30. Financial stress was assessed as household ability to make ends meet (i) pre-diagnosis and (ii) at questionnaire completion (post-diagnosis). Multivariable logistic regression was used to relate financial stress to clinically important CRF (fatigue subscale score ≥ 39 of a possible 100).ResultsTwo thousand four hundred fifty-eight PCa survivors were included. Of these, 268 (10.9%) reported pre-diagnosis financial stress only, 317 (12.9%) post-diagnosis stress only and 270 (11.0%) both pre- and post-diagnosis stress (cumulative stress); 470 (19.1%) reported clinically important CRF. After controlling for confounders, survivors with cumulative financial stress exposure were significantly more likely to have CRF (OR = 4.58, 95% CI 3.30–6.35, p < 0.001), compared with those without financial stress. There was a suggestion of a dose-response relationship (OR = 1.83, 95% CI 1.27–2.65, p = 0.001 for pre-diagnosis financial stress only; and OR = 4.11, 95% CI 3.01–5.61, p < 0.001 for post-diagnosis financial stress only).ConclusionsFinancial stress may be an independent risk factor for CRF.Implications for Cancer SurvivorsThere may be benefits in targeting interventions for reducing CRF towards survivors with financial stress, or developing strategies to reduce financial stress.

Highlights

  • Cancer-related fatigue (CRF) is the most commonly reported treatment-related side effect of prostate cancer (PCa)

  • We found that PCa survivors had worse scores for fatigue than any other general cancer-related symptoms recorded on the EORTC QLQ-C30 [11]

  • The Prostate Cancer Treatment-your experience (PiCTure) study was a cross-sectional study of PCa survivors sampled and recruited via two population-based cancer registries on the island of Ireland: the National Cancer Registry Ireland (NCRI) in the Republic of Ireland (RoI) and the Northern Ireland (NI) Cancer Registry (NICR)

Read more

Summary

Introduction

Cancer-related fatigue (CRF) is the most commonly reported treatment-related side effect of prostate cancer (PCa). Cancer-related fatigue (CRF) is a prolonged, distressing and subjective sense of physical, emotional or cognitive exhaustion associated with cancer or its treatment [7]. It can result from current mainstream treatments for PCa, androgen deprivation therapy (ADT) [8]. It is the most commonly reported treatment-related side effect of PCa [9, 10]. Others have reported that CRF may be found in up to three-quarters

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.